Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0
2017
Purpose
Investigate in patients with metastatic and/or irresectable colorectal cancer treated with systemic treatment with capecitabine or TAS-102 whether:
1.
Intestinal microbiota composition can act as a predictor for response.
2.
Intestinal microbiota composition changes during systemic treatment and its relation to chemotoxicity.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
13
Citations
NaN
KQI